The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIVAX SA AMERICAN DEPOSITARY SHARES | ADRS | 00370M103 | 37,853,725 | 6,056,596 | SH | SOLE | 6,056,596 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COMM | 00773U207 | 7,850,626 | 1,796,482 | SH | SOLE | 1,796,482 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COMM | 008064107 | 5,624,431 | 2,240,809 | SH | SOLE | 2,240,809 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COMM | 03237H101 | 21,041,094 | 5,943,812 | SH | SOLE | 5,943,812 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COMM | 04635X102 | 14,748,338 | 2,761,861 | SH | SOLE | 2,761,861 | 0 | 0 | ||
AVALO THERAPEUTICS INC | COMM | 05338F306 | 3,868,830 | 483,000 | SH | SOLE | 483,000 | 0 | 0 | ||
CABALETTA BIO INC | COMM | 12674W109 | 120,211 | 86,795 | SH | SOLE | 86,795 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COMM | 171757206 | 21,667,108 | 1,005,901 | SH | SOLE | 1,005,901 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | ADRS | 152309100 | 41,569,934 | 2,890,816 | SH | SOLE | 2,890,816 | 0 | 0 | ||
CG ONCOLOGY INC | COMM | 156944100 | 89,883,345 | 3,670,206 | SH | SOLE | 3,670,206 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COMM | 19240Q201 | 41,716,606 | 6,964,375 | SH | SOLE | 6,964,375 | 0 | 0 | ||
COMPASS PATHWAYS LTD | ADRS | 20451W101 | 11,033,880 | 3,858,000 | SH | SOLE | 3,858,000 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COMM | 252828108 | 27,239,459 | 1,501,624 | SH | SOLE | 1,501,624 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COMM | 26818M108 | 27,720,569 | 2,650,150 | SH | SOLE | 2,650,150 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COMM | 30233G209 | 19,362,056 | 3,572,335 | SH | SOLE | 3,572,335 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COMM | 359616109 | 15,120,000 | 5,250,000 | SH | SOLE | 5,250,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | ADRS | 86366E106 | 18,400,530 | 1,063,000 | SH | SOLE | 1,063,000 | 0 | 0 | ||
DISC MEDICINE INC | COMM | 254604101 | 23,095,357 | 465,257 | SH | SOLE | 465,257 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COMM | 492327101 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | ||
KODIAK SCIENCES INC | COMM | 50015M109 | 3,213,234 | 1,145,538 | SH | SOLE | 1,145,538 | 0 | 0 | ||
KURA ONCOLOGY INC | COMM | 50127T109 | 9,396,037 | 1,423,642 | SH | SOLE | 1,423,642 | 0 | 0 | ||
MBX BIOSCIENCES INC | COMM | 55287L101 | 4,797,000 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COMM | 603170101 | 39,227,808 | 2,470,265 | SH | SOLE | 2,470,265 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COMM | 640268108 | 2,720,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COMM | 67576A100 | 38,989,355 | 5,319,148 | SH | SOLE | 5,319,148 | 0 | 0 | ||
RAPT Therapeutics, Inc. | COMM | 75382E109 | 15,970,044 | 13,090,200 | SH | SOLE | 13,090,200 | 0 | 0 | ||
SAVARA INC | COMM | 805111101 | 34,243,308 | 12,362,205 | SH | SOLE | 12,362,205 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADRS | 82686Q101 | 8,554,639 | 3,033,560 | SH | SOLE | 3,033,560 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COMM | 834203309 | 19,648,750 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COMM | 88427A107 | 8,693,821 | 2,505,424 | SH | SOLE | 2,505,424 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COMM | 87583X109 | 14,708,320 | 10,736,000 | SH | SOLE | 10,736,000 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COMM | 29384C108 | 5,287,993 | 584,955 | SH | SOLE | 584,955 | 0 | 0 | ||
TOURMALINE BIO INC | COMM | 89157D105 | 22,474,190 | 1,477,593 | SH | SOLE | 1,477,593 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COMM | 90240B106 | 26,952,358 | 2,898,103 | SH | SOLE | 2,898,103 | 0 | 0 | ||
UPSTREAM BIO INC | COMM | 91678A107 | 17,146,790 | 2,801,763 | SH | SOLE | 2,801,763 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COMM | 92332V107 | 363,624 | 316,195 | SH | SOLE | 316,195 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COMM | 92840H400 | 6,691,451 | 2,676,580 | SH | SOLE | 2,676,580 | 0 | 0 | ||
XENCOR INC | COMM | 98401F105 | 26,090,748 | 2,452,138 | SH | SOLE | 2,452,138 | 0 | 0 |